These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 29286069)
21. Identification of risk genes associated with myocardial infarction based on the recursive feature elimination algorithm and support vector machine classifier. Yang X Mol Med Rep; 2018 Jan; 17(1):1555-1560. PubMed ID: 29138828 [TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer. Chen J; Wu R; Xuan Y; Jiang M; Zeng Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
24. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data. Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975 [TBL] [Abstract][Full Text] [Related]
25. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma. Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732 [TBL] [Abstract][Full Text] [Related]
26. A 80-gene set potentially predicts the relapse in laryngeal carcinoma optimized by support vector machine. Yang B; Guo Q; Wang F; Cai K; Bao X; Chu J Cancer Biomark; 2017; 19(1):65-73. PubMed ID: 28269752 [TBL] [Abstract][Full Text] [Related]
27. Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma. Zhang C; Huang Y; Fang C; Liang Y; Jiang D; Li J; Ma H; Jiang W; Feng Y Cancer Biomark; 2023; 36(4):313-326. PubMed ID: 36938730 [TBL] [Abstract][Full Text] [Related]
28. Differentially expressed EREG and SPP1 are independent prognostic markers in cervical squamous cell carcinoma. Zhang L; Nan F; Yang L; Dong Y; Tian Y J Obstet Gynaecol Res; 2022 Jul; 48(7):1848-1858. PubMed ID: 35491469 [TBL] [Abstract][Full Text] [Related]
29. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma. Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703 [TBL] [Abstract][Full Text] [Related]
30. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival. Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034 [TBL] [Abstract][Full Text] [Related]
31. Screening pathogenic genes in oral squamous cell carcinoma based on the mRNA expression microarray data. Ding Y; Liu P; Zhang S; Tao L; Han J Int J Mol Med; 2018 Jun; 41(6):3597-3603. PubMed ID: 29512771 [TBL] [Abstract][Full Text] [Related]
32. Identification of biomarkers with a tumor stage-dependent expression and exploration of the mechanism involved in laryngeal squamous cell carcinoma. Hui L; Yang N; Yang H; Guo X; Jang X Oncol Rep; 2015 Nov; 34(5):2627-35. PubMed ID: 26323359 [TBL] [Abstract][Full Text] [Related]
33. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma. Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270 [TBL] [Abstract][Full Text] [Related]
34. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
35. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Yang Q; Gong H; Liu J; Ye M; Zou W; Li H Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696 [TBL] [Abstract][Full Text] [Related]
36. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
37. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer. Wu Z; Wang YM; Dai Y; Chen LA Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567 [TBL] [Abstract][Full Text] [Related]
38. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis. Xu Z; Jiang P; He S Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546 [TBL] [Abstract][Full Text] [Related]
39. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis. Shang M; Zhang L; Chen X; Zheng S Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587 [TBL] [Abstract][Full Text] [Related]
40. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer. Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]